Clay Siegall Is Doing A Lot Of Work In The Healthcare Sector

Cancer is a deadly disease that continues to kill people all across the world. This is why many organization, as well as research centers, are working hard to research and analyze in order to find a cure for this deadly disease.

 

Clay Siegall is well-known as a leading scientist. He has invested a lot of his time and other resources in conducting research. His focus is on eradicating cancer from the world. He is the President, Chief Executive Officer as well as Chairman of the Board of Director of Seattle Genetics.

 

It was in 1998 that he co-founded Seattle Genetics. Since then the company has continued to develop some of the best antibody-based therapies for people suffering from cancer. This treatment has helped to mitigate the effects of this disease.

 

Clay Siegall has done his graduation in Zoology from the Maryland University. He has done his Ph. D. in Genetics. He earned this from the George Washington University. After that Clay Siegall built his career in scientific research. Today he is among the most successful as well as recognized scientists in the field of medical research with regard to cancer therapies

 

He is responsible for securing funds for his company. Clay Siegall initiated it through public participation. It was in 2001 that he helped Seattle Genetics in raising more than 300 million dollars. This was from the general public. This money was used to improve research in his center.

 

Clay Siegall has contributed personally and professionally at Seattle Genetics. This is why they continue to improve on their results.

 

Clay Siegall also contributes by signing agreements in order to form a partnership with several other multinational companies all across the world. This is done in order to improve service delivery. Seattle Genetics has just entered into a partnership with Genentech. This deal is worth $800 million.

 

He had worked in many other organizations before he founded Seattle Genetics. He was with Bristol-Myers Squibb Pharmaceutical Research Institute from 1991 to 1997. What he learned here helped him to reach great heights in his field of research and analysis. Clay Siegall has helped in the mitigation of cancer in a big way.